ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Using the Digital EEG Spectral Analysis in Assessing Neuroelectrical Processing Abnormalities in Autism

This study is not yet open for participant recruitment.
Study NCT00693953.   Last updated on October 14, 2008.   Information provided by Yellen & Associates, Inc.

This Tabular View shows the required WHO registration data elements as marked by

Descriptive Information Fields
Brief Title  Using the Digital EEG Spectral Analysis in Assessing Neuroelectrical Processing Abnormalities in Autism
Official Title  Using the Digital EEG Spectral Analysis in Assessing Neuroelectrical Processing Abnormalities in Autism
Brief Summary

Individuals with Autism Spectrum Disorder will have abnormal DESA® results. Our objective is to use neuroelectrical measures to determine the degree of processing abnormalities in individuals with Autism. The study will survey processing patterns and will locate and evaluate the degree(s) of abnormalities for further study. The abnormal results of comprehensive neuroelectrical evaluations of individuals with Autism when compared to the normative database will provide objective, verifiable, neurophysiological information with which to form novel approaches to the disorder.

Detailed Description

The research method will be: gathering, analyzing and utilizing data.

We will observe research subjects through neuroelectrical instrumentation, then, compare results to retrospective information collected from research subjects and a normative database.

A qualified neurologist thoroughly familiar with electrophysiology will interpret the data, and analyze it to explore the abnormalities.

The hypothesis will be evaluated.

We will, then, utilize the results to find data-based forms of treatment for those with the disorder.

Study Phase
Study Type  Observational
Study Design  Case Control, Other
Primary Outcome Measure 
Secondary Outcome Measure 
Condition  Autistic Disorder
Autism, Early Infantile
Autism, Infantile
Asperger Syndrome
Intervention 
MEDLINE PMIDs
Links
Recruitment Information Fields
Recruitment Status  Not yet recruiting
Enrollment  200
Start Date  January 2009
Completion Date December 2010
Eligibility Criteria 

Inclusion Criteria:

  • The study will include children between the ages of five and eighteen, adults from the age of nineteen to twenty-five, and those with the diagnosis of Autism and Autism Spectrum Disorders.

Exclusion Criteria:

  • those with mental retardation
  • those with any other neurological disorder
  • those that cannot sit in a chair for one hundred and fifty minutes
  • those that have been previously diagnosed with a seizure disorder
  • those who are blind and/or deaf
  • those who are not ambulatory
  • those who cannot understand English
  • those that are not a resident of Los Angeles County
Gender Both
Ages 5 Years to 25 Years
Accepts Healthy Volunteers No
Contacts ††
Location Countries  United States
Administrative Information Fields
NCT ID  NCT00693953
Organization ID PA-06-278
Secondary IDs ††
Study Sponsor  Yellen & Associates, Inc.
Collaborators ††
Investigators 
Principal Investigator:     Andrew G Yellen, PhD     President, Yellen & Associates, Inc.    
Study Chair:     Thomas Schweller, MD     Neurologist    
Information Provided By Yellen & Associates, Inc.
Verification Date October 2008
First Received Date  June 5, 2008
Last Updated Date October 14, 2008

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.




Links to all studies - primarily for crawlers